ELAC2

gene product
FLJ10530, HPC2
The protein encoded by this gene has a C-terminal domain with tRNA 3′ processing endoribonuclease activity, which catalyzes the removal of the 3' trailer from precursor tRNAs. The protein also interacts with activated Smad family member 2 (Smad2) and its nuclear partner forkhead box H1 (also known as FAST-1), and reduced expression can suppress transforming growth factor-beta induced growth arrest. Mutations in this gene result in an increased risk of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Antibodypedia Validation Initiative

Validation method

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Validated by best practice
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
109 antibodies from 21 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeAVIWBELICCIPIHCFC
Atlas Antibodies
1 antibody
Novus Biologicals
5 antibodies
LifeSpan BioSciences, Inc.
13 antibodies
Bioworld Technology, Inc
1 antibody
Bethyl Laboratories, Inc.
6 antibodies
Abnova Corporation
4 antibodies
Biorbyt
8 antibodies
NovoPro Bioscience Inc.
1 antibody
Proteintech Group
1 antibody
antibodies-online
39 antibodies
Acris Antibodies GmbH
2 antibodies
Aviva Systems Biology
2 antibodies
Invitrogen Antibodies
1 antibody
OriGene
1 antibody
GeneTex
3 antibodies
MyBioSource
2 antibodies
St John's Laboratory
2 antibodies
Sigma-Aldrich
3 antibodies
RayBiotech, Inc.
1 antibody
United States Biological
1 antibody